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ABSTRACT 
Biopolymers such as chitosan and xanthan gum were applied as matrix component for fabrication into tablet using a direct 
compression technique to control the release of propranolol HCl. Covering both planar surfaces of middle tablet with polymeric 
mixture containing chitosan-xanthan gum-lactose could modulate the release of propranolol HCl. Increased amount of lactose 
enhanced the drug release and diminished the pH sensitive drug release of tablet containing chitosan and xanthan gum. 
However, the drug release from the three layer tablets comprising this system was pH dependent. Particle size of chitosan did 
not significantly affect the drug release from the three layer tablets comprising this system. The drug release behaviour from the 
developed tablets was characterized with the curve fitting with different mathematical equations and the water & erosion studies. 
Key words: chitosan, drug release layered matrix, particle size, xanthan gum  
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Introduction
§Matrix diffusion seems to be a suitable system in 
producing oral sustained release dosage form, especially 
tablet, in term of the economic and scale-up process. It 
can be achieved by using appropriate type and 
concentration of a matrix substance, followed by a 
general tablet manufacturing such as compression. 
Matrix system comprising chitosan and xanthan gum was 
claimed to sustain the release of water soluble drug. FT-
IR and DSC studies exhibited the charge interaction 
between NH3+ of chitosan molecule and COO- of acetate 
or pyruvate groups of xanthan gum molecule of this 
matrix system.1  
Three-layer matrix tablets have been investigated on 
different core or barrier composition. Linear release 
profiles could be obtained by applying hydrophilic barrier 
layers on both faces of the hydrophobic matrix tablet, or 
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by applying a hydrophilic barrier layer on one face and a 
hydrophobic barrier layer on the other face of the matrix 
tablet.2-4 Increasing the amount of matrix in barrier or in 
middle layer of the three layer tablet containing chitosan 
and xanthan gum resulted in prolongation of drug 
release.1  Furthermore, the investigation of drug release 
from one planar surface demonstrated that the lag time 
for drug release through barrier layer was apparently 
longer as the amount of barrier was enhanced.1 Except 
for the amount of polymer used, the particle sizes of 
polymer was also a decisive factors in controlling release 
rates of drug from matrix tablet.5 Some investigation 
revealed that the coarse fractions of hydroxypropyl 
methyl cellulose (HPMC) hydrated too slowly to allow 
sustained release.6 As the content proportion of HPMC 
was higher, the effect of the particle size was less 
important on the release of propranolol hydrochloride, 
while the effect of this variable was more important when 
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the content of this polymer was low,. However HPMC 
particles in certain areas of the matrices containing low 
levels of HPMC led to burst release.7 The behaviour and 
function of the particle size of HPMC have also been 
explained by its fibre content and the resultant problems 
encountered in sieving fibre-like materials.8 Thus, the 
different particle size ranges may not only differ in their 
size but also in the shape or morphology of the 
particles.9 The guaifenesin release rate was dependent 
upon the particle size of ethyl cellulose and the 
processing conditions employed to prepare the tablets. 
The guaifenesin release rate was slower in tablets 
prepared with the “fine” ethyl cellulose particle size 
fraction due to the presence of fewer soluble drug 
clusters within the matrix. Tablets prepared by direct 
compression using “coarse” ethyl cellulose were found to 
release guaifenesin by both diffusion and erosion.10 
Although considerable research has been done on 
such above mentioned manner, the investigation of the 
effect of particle size of chitosan on the drug release 
from layered matrix containing two polymers which could 
form the polyelectrolyte complex such as chitosan and 
xanthan gum has not been addressed. Additionally, the 
effect of an incorporation of lactose on drug release and 
effect of pH of dissolution medium on the matrix system 
comprising chitosan and xanthan gum should be 
investigated. Therefore, the current investigation dealt 
with the evaluation the effect of lactose and particle size 
of chitosan on physical properties and release of 
propranolol HCl from three-layer tablet comprising 
chitosan and xanthan gum.  
 
Material and Methods  
 
Materials 
Chitosan (Aqua Premier, Chonburi, Thailand) having 
a degree of deacetylation of 99.3% and molecular weight 
of 137 kDa with different particle sizes were prepared by 
grinding chitosan powder with Fitz mill (Kan Seng Lee 
Factory Ltd., Bangkok, Thailand) and then were 
separated using sieve shaker. The chitosan powder 
passing through sieve No. 40, 60, 80, 100 and 200 
meshes were used to prepare the tablets. Xanthan gum 
(Xantural 75, CP Kelco U.S., Inc. Chicago, USA) was 
used as received. Propranolol hydrochloride (Batch No. 
941002) was purchased from China National Chemical 
Imp. & Exp., Shanghai, China. Lactose was purchased 
from Wyndale, Hawera, New Zealand. Magnesium 
stearate (Lot No. MAF 07, P. C. Drug Center Co.) was 
passed through sieve No. 80 mesh before used. Sodium 
chloride (Lot k20420804, Merk, E Merck, Darmstadt, 
Germany) was used as received. All other reagents were 
of AR grade. 
 
Preparation of matrix tablets 
The 400-mg tablets containing propranolol HCl were 
prepared by direct compression method. The tablets 
containing chitosan and xanthan gum in the ratio of 1:1 
with various amount of lactose were prepared according 
to the composition in Table 1. The amount of lactose 
was varied from 25 to 75 % of the matrix component 
excluding the amount of drug and magnesium stearate. 
The concentration of drug was kept constantly at 20% by 
weight (80 mg/tablet). To make the powder mixture, the 
drug, polymers and lactose were mixed with magnesium 
stearate for 5 minutes with mortar and pestle. Then the 
blended drug powder of 400 mg was compressed into a 
tablet at a compression force of two tons using 13 mm 
round, flat and plain punches on a hydraulic press 
(Carver Press, WI). The percent compositions of barrier 
for the layered matrix tablets are shown in Table 2.  
 
Table 1 Percent composition of different single layer 
formulations containing lactose with different 
concentrations*   
Formulation (% w/w) Substances 
L25 L50 L75 
Propranolol HCl 20.00 20.00 20.00 
Chitosan 29.25 19.50 9.75 
Xanthan gum 29.25 19.50 9.75 
Lactose 19.50 39.00 58.50 
Magnesium stearate 2.00 2.00 2.00 
* L25, L50 and L75 = formulations containing lactose of 25%, 50% and 
75% of the matrix component respectively.   
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Table 2 Percent composition of barrier.  
Substance Formulations (%,w/w) 
Chitosan 12.25 
Xanthan gum 12.25 
Lactose 73.5 
Magnesium stearate 2 
 
Layered matrix tablets were prepared by adding 100 
mg of the powder mixture without drug in the die cavity 
and slightly compressed for uniform spreading. The 400 
mg of the powder mixture with drug was placed over the 
first layer and again slightly compressed for uniform 
spreading. Another 100 mg of the powder mixture 
without drug was subsequently placed and compressed 
with a two tons force using a hydraulic press to obtain 
the three-layer tablet. The dwell time after target 
pressure achieved was 10 sec.  
 
Evaluation of matrix tablets 
The hardness of tablets was determined using a 
hardness tester (Pharmatest, USA). The tablet thickness 
and diameter were measured using a thickness tester 
(Teclock, Japan). The friability was determined as the 
percent weight loss of 20 tablets. Twenty tablets were 
weighed and rotated for 100 revolutions in 4 min in a 
friabilator (Yieheng Engineering, Bangkok, Thailand). The 
tablets were then weighed again and the percentage 
friability was calculated. A test of drug release was 
undertaken using a dissolution apparatus (Prolabo, 
France) with the basket method at 100 rpm. A volume of 
900 mL of HCl buffer pH 1.2 equilibrated at 37 °C was 
utilized as dissolution fluid. Samples were collected at 
specific time intervals and assayed by a UV-Vis 
spectrophotometer (Perkin-Elmer, Germany) at a 
wavelength of 320 nm. To study the effect of the 
dissolution fluid on release behavior, the drug release 
tests in distilled water, phosphate buffer pH 6.8 and pH 
change were also undertaken. For the dissolution test 
with pH change, the drug released in HCl buffer pH 1.2 
was conducted for one and a half hour. Then the pH was 
raised to 6.8 by adding 4.6 g sodium hydroxide, 3.06 g 
monobasic potassium phosphate and 4.005 g dibasic 
sodium phosphate. The operation was continued for 12 
hours. During the drug release studies, the tablets were 
observed for physical integrity.  
 
Dissolution profile fitting 
Least square fitting the experimental dissolution data 
(cumulative drug release > 10% and up to 80%) to the 
mathematical equations (power law, first order, Higuchi’s 
and zero order) was carried out using a nonlinear 
computer programme, Scientist for Windows, version 2.1 
(MicroMath Scientific Software, Salt Lake City, UT, USA). 
The coefficient of determination (r2) was used to indicate 
the degree of curve fitting. Goodness-of-fit was also 
evaluated using the Model Selection Criterion (MSC)11, 
given below.  
  
 
Where Yobsi and Ycali are observed and calculated 
values of the i-th point, respectively, and wi is the weight 
that applies to the i-th point, n is number of points and p 
is number of parameters.   
 
Water uptake study and erosion study 
The tablet water uptake and erosion studies were 
done using the same condition of dissolution study. The 
weight of tablet (W0) was determined before tested. At 
selected time intervals, the tablets were withdrawn, 
blotted to remove excess water, weighed for wet weight 
(W1), then was taken place into the hot air oven at 80  
°C until the tablet weight did not change and weighed for 
dry weight (W2). Swelling and erosion characteristics of 
the tablets were expressed in terms of water uptake (%) 
and mass loss (%) as following.12 
  
  Water uptake (%)  = (W1 - W2) × 100  
             W2 
  Mass loss (%)   = (W0 - W2) × 100  
           W0 
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Results and Discussions  
Physical properties of matrix tablets 
The data on weight, thickness, friability and hardness 
of the single and the three-layered tablets are presented 
in Table 3. The hardness of tablet decreased as the 
amount of lactose was increased. The hardness of 
layered tablet increased as the smaller chitosan powder 
was utilized since the distance between particles was 
less than that using the larger chitosan powder. The 
friability of tablets tended to decrease as the smaller 
chitosan powder was utilized. Friability values of all 
formulations were less than 1% except the tablet 
containing lactose 50%.  
 
Table 3 Physical properties of prepared tablets  
Formulation§ 
Weight (mg)*  
(n = 20) 
Thickness(mm)* 
(n = 10) 
Friability (%) 
(n = 20) 
Hardness (Newton)* 
(n = 10) 
L25 401.60 ± 8.10 2.34 ± 0.08 0.73 60.56 ± 8.19 
L50 402.56 ± 10.12 2.24 ± 0.03 1.08 36.03 ± 4.58 
L75 402.83 ± 7.82 2.25 ± 0.02 0.92 33.39 + 5.37 
L75, 3-layer, 40 mesh 596.42 ± 4.82 3.51 ± 0.09 0.65 31.88 ± 1.38 
L75, 3-layer, 60 mesh 590.72 ± 2.91 3.49 ± 0.09 0.71 32.66 ± 2.42 
L75, 3-layer, 80 mesh 598.14 ± 8.53 3.40 ± 0.04 0.62 33.06 ± 3.69 
L75, 3-layer, 100 mesh 596.29 ± 6.82 3.51 ± 0.04 0.45 37.18 ± 3.49 
L75, 3-layer, 200 mesh 595.02 ± 4.83 3.48 ± 0.02 0.31 39.41 ± 4.61 
* Presented as mean ± S.D,  
§ L25, L50 and L75 = formulations containing lactose of 25%, 50% and 75% of the matrix component respectively.  
 
 
In Vitro Drug Release 
Increasing the amount of lactose in 400-mg tablet 
containing 1:1 chitosan:xanthan gum led to faster drug 
release as presented in Figure 1. The effect of 
pharmaceutical diluents on drug release from matrix 
devices was claimed to be mainly due to a change in 
hydrophilic gel expansion.13 These findings were in good 
agreement of results obtained with diphenhydramine HCl 
released from polyvinylacetate/polyvinylpyrrolidone matrix 
containing lactose or maize starch.14 Lactose, by its 
water soluble and hydrophilic nature, facilitated gel 
formation; hence, the time taken for the dissolution 
medium to permeate to the core was shorter as the 
amount of this soluble substance was increased. 
Moreover, soluble substance acted as a channeling 
agent, by rapidly dissolving and easily diffusing outward, 
therefore allowed a decrease in tortuosity and/or an 
increase in the matrix porosity.15-17 However, the 
sustainable drug release could be obtained for the matrix 
containing chitosan and xanthan gum. Ionic interaction 
between chitosan and xanthan gum decreased the rate 
of polymer dissolution and the rate of solvent 
penetration, therefore the drug diffusion into dissolution 
medium was diminished.  
Curve upward of dissolution profile appeared during 
pH change as shown in Figure 1. The pH dependence of 
drug release was decreased as the amount of lactose 
was increased. Moreover, the dissolution profile in HCl 
buffer pH 1.2 was closer to that in pH change media as 
the amount of lactose was increased. The difference was 
apparently minimized in case of the tablet containing 
75% lactose. Therefore, lactose could adjust a pH 
sensitive property of polymeric matrix containing chitosan 
and xanthan gum due to the reduced amount of 
chitosan-xanthan gum in the tablet, since the amount of 
chitosan-xanthan gum played important role in liquid 
uptake, erosion and swelling of compact matrix. 
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However, one of the popular methods to obtain the pH 
independent drug release was the adjustment of the 
environmental pH in dosage forms. Dissolution profile of 
drug from alginate matrices was different upon increase 
of pH. In order to obtain pH-independent drug release, 
usually pH-modifier agent such as organic acids was 
used for matrix containing weak basic drugs to keep the 
pH in the intestinal pH range low and thus the drug 
solubility was high.14,18  
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Figure 1 Dissolution profiles of propranolol HCl from 
single layer tablets containing 1:1 chitosan: 
xanthan gum and lactose of 25% (L25), 50% 
(L50) and 75% (L75) in different dissolution 
fluids. Each point represents the mean ± 
S.D., n = 3. 
Effect of polymeric layering on drug release was 
illustrated in Figure 2. The drug release from three-layer 
tablet was obviously slower than that of single layer 
tablet. Drug release from the middle layer could be 
modified by the delayed diffusion from the two coated 
surfaces as a result of simple diffusion. The compression 
with polymeric layers on both sides of tablet could 
prolong and modify the drug release to achieve a 
constant release rate. Zero-order release could be 
qualitatively explained by assuming that the decreasing 
release rate from the lateral surface of the middle layer 
was balanced by delayed diffusion through the two 
laminated faces as a result of increasing polymer 
hydration/dissolution over time. The early drug release 
was the diffusion of dissolved drug molecules through 
cylindrical side surface of the tablet. The coated layers 
were designed to initially delay the hydration rate of the 
middle layer. The external layers would disappear 
gradually at disproportionate rates, creating more surface 
area for drug diffusion, thus counterbalancing the 
reduction of diffusing surface area due to the erosion as 
well as the increase in diffusional path-length due to 
continuous system swelling.19  
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Figure 2 Dissolution profiles of propranolol HCl from 
single layer (L75) and three layer (L75 3L) 
tablets containing 1:1 chitosan:xanthan gum 
and lactose 75% in HCl buffer pH 1.2. Each 
point represents the mean ± S.D., n = 3. 
 
Particle size of chitosan did not significantly affect the 
drug release of three layer tablet (Figure 3). Since the 
polymeric matrix could hydrate and form gel rapidly to 
L25 
L50 
L75 
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modulate the drug release, the difference of distance 
between particles of polymers could not affect 
significantly to the drug diffusion. Additionally, porosity of 
the hydrated matrix was independent of the initial 
porosity, the difference of particle size posed to have 
little influence on drug release.9 Some studies 
demonstrated that the guaifenesin release rate was 
dependent upon the particle size of ethyl cellulose 
employed to prepare the tablets. The guaifenesin release 
rate was slower in tablets prepared with the “fine” ethyl 
cellulose particle size fraction due to the presence of 
fewer soluble drug clusters within the matrix. Tablets 
prepared by direct compression using “coarse” ethyl 
cellulose were found to release guaifenesin by both 
diffusion and erosion.10 Alderman (1984)6 stated that 
coarse fractions of HPMC hydrate too slowly to allow 
sustained release. Later, Mitchell et al. (1993)7 indicated 
that, when the content of HPMC is higher, the effect of 
the particle size is less important on the release of 
propranolol hydrochloride, while the effect of this variable 
was more important when the content of this polymer 
was low. 
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Figure 3 Effect of particle size of chitosan on dissolution 
profiles of propranolol HCl from three-layer 
tablets containing the 400 mg middle layer of 
1:1 chitosan:xanthan gum and 75% lactose with 
the 100-mg upper and 100-mg lower barriers in 
pH change media. Each point represents the 
mean ± S.D., n = 3. 
 
 By comparison, the drug release from the three-layer 
tablets prepared from 40 mesh chitosan in distilled water 
was faster than that in pH change, HCl buffer pH 1.2 and 
phosphate buffer pH 6.8, respectively (Figure  4A). While 
the drug release from the three-layer tablets prepared 
from 200 mesh into HCL buffer 1.2 was rather slower 
than the others as shown in Figure 4B. This indicated 
that this drug release was pH dependent. Propranolol 
HCl, an anionic basic drug with a pKa of 9.45, should be 
more soluble in acidic environment than in neutral and 
alkaline environment, respectively. However this 
anticipation was not found as the drug solubility in 
deionized water was greater than that in acid and basic 
dissolution fluids respectively. The decline of solubility in 
HCl buffer pH 1.2 was attributed to the common-ion 
(chloride) effect, which provided an unexpected trend in 
solubility of this medicament in the presence of chloride 
ion in this acidic medium. Therefore, the release of 
propranolol in HCl buffer pH 1.2 was slower than that in 
distilled water. This evidence was also noted by Rekhi et 
al. (1989)20 and Takka et al. (2001).21 In addition, the pH 
dependence on dissolution of this drug from matrices 
containing HPMC and carbopol was reported.18 This can 
be explained by the difference of charge balance inside 
the gel immersed in different dissolution fluids. The 
degree of interaction between the two polymers was 
modified by the environmental pH; thereafter the swelling 
of the complex was changed.22 Polyacid of xanthan gum 
was neutralized in acidic medium due to free ammonium 
groups of chitosan; therefore, the positive charges 
appeared dominantly inside the gel. The mutual repulsion 
and the entry of water together with counterions to 
neutralize these charges caused matrix swelling. In 
neutral or basic medium, the mechanism is the same but 
the swelling was performed by the free negative charges 
of xanthan gum. In pH change system, rate of drug 
release apparently increased after adding buffering 
agents since the rapid pH alteration during pH change 
process induced the adjustment of matrix charge density 
which influenced the drug release. Normally, the small 
particle chitosan (200 mesh) could protonate and form 
sticky gel than the large particle chitosan (40 mesh) in 
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acid environment. Therefore the drug release from the 
three-layer tablets prepared from 200 mesh into HCL 
buffer 1.2 was rather slower than the others. 
 
0
20
40
60
80
100
120
0 200 400 600 800
Time (min)
%
R
el
ea
se
Distilled water
HCl buffer pH 1.2
Phosphate buffer pH 6.8
pH change
 
(A) 
 
0
20
40
60
80
100
120
0 200 400 600 800
Time (min)
%
R
el
ea
se
Distilled water
HCl buffer pH 1.2
Phos phate buffer pH 6.8
pH change
 
(B)  
 
Figure 4 Effect of dissolution medium on release of 
propranolol HCl from three-layer tablets 
containing the 400 mg middle layer of 1:1 
chitosan:xanthan gum and 75% lactose with 
the 100-mg upper and 100-mg lower barrier 
using chitosan 40 mesh passed (A) and 200 
mesh passed (B).  Each point represents the 
mean ± S.D., n = 3. 
 
Dissolution profile fitting 
The kinetics of propranolol HCl release from the 
developed matrices was analyzed using the power law 
expression. This equation (an empirical equation) gained 
popularity for analysis of release data.23 The n value 
from power law is the diffusional exponent which 
characterizes the transport mechanism of the drug. The 
transport mechanisms are classified based on the value 
that n assumes. For a cylinder, the mechanism of drug 
transport is described by Fickian diffusion when n = 0.45. 
When 0.45 < n < 0.89, it indicates anomalous (non-
Fickian) transport and for values of n = 0.89, Case II or 
zero order release kinetics is indicated.24 Case II relates 
to polymer relaxation, while non-Fickian release is 
described by two mechanisms; the coupling of drug 
diffusion and polymer relaxation.23,25 
The large value of coefficient of determination (r2) or 
model selection criteria (MSC) indicated a superiority of 
the dissolution profile fitting to mathematical equations. 
The r2 and MSC from curve fitting to power law, first 
order, Higuchi’s and zero order equations are shown in 
Table 4. The estimated parameters from curve fitting to 
power law equation are presented in Table 5. Fitting 
experimental drug dissolution profiles to power law 
equation provided high r2 (a range of 0.9767 - 0.9999) 
and high MSC (a range of 3.26 - 8.87), indicating a 
superiority of this model. However, these values were 
rather low in the case of the drug release from single 
layer tablet containing 1:1 chitosan:xanthan gum and 
lactose 25% (L25) in pH change (r2 = 0.9420, MSC = 
2.45).  
There was a tendency of the shift of drug release 
both in HCl buffer pH 1.2 and pH change to zero order 
kinetic as the amount of lactose was increased. Addition 
of lactose could diminish the pH dependent release of 
this drug from chitosan-xanthan gum matrix tablets. 
Release profiles and swelling rates of hydrophilic matrix 
were found to be highly influenced by the type and 
amount of pharmaceutical excipients incorporated which 
changed the hydrophilic gel expansion and the 
interactions between the drug and polymer.13 
By comparison, the dissolution profiles of three-layer 
tablets in HCl buffer pH 1.2 could better fit to zero order 
kinetic than first order and Higuchi’s equation, 
respectively. The curve fitting to zero order kinetic gave 
the large values of r2 (0.9972) and MSC (5.51) (Table 4). 
It is suggested from these data that the developed three-
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layer tablets showed zero-order or Case II release. The 
values of the kinetic constant (k) were in accordance with 
the values of n, the diffusional exponent, with k having 
lower values when the transport mechanism was Case II 
and higher values for formulations that released the drug 
by Fickian diffusion. The alteration of these estimated 
parameters as mentioned above was previously 
reported.23,25 The relationship characteristics of these two 
estimated parameters are shown in Table 5. However, 
the dissolution profiles of some three-layer tablets in 
other dissolution fluids could be best fitted with first order 
equation (Table 4). Therefore the drug release 
characteristic was pH dependent. Difference of gel 
forming and erosion of tablets in different dissolution 
fluids could change the drug diffusion from these 
controlled release devices. The rate of drug release into 
distilled water was higher than that into HCl buffer pH 
1.2, pH change and phosphate buffer pH 6.8, 
respectively (Figures 4).  
 
 
Table 4 Comparison of degree of goodness-of-fit from curve fitting of drug dissolution in HCl buffer pH 1.2 to different 
release models*   
Power law First order Higuchi’s Zero order Tablet 
r2 MSC r2 MSC r2 MSC r2 MSC 
L25 0.9998 7.99 0.9976 5.73 0.9870 4.03 0.9874 4.07 
L50 0.9994 6.85 0.9981 5.95 0.9917 4.45 0.9798 3.57 
L75 0.9999 8.87 0.9919 4.37 0.9736 3.19 0.9958 5.02 
L25a 0.9420 2.45 0.9557 2.85 0.9355 2.48 0.8808 1.86 
L50 a 0.9767 3.26 0.9627 2.96 0.9226 2.23 0.9746 3.34 
L75 a 0.9980 5.36 0.9385 2.29 0.8718 1.55 0.9814 3.49 
L75 3-layer 0.9989 6.24 0.9806 3.58 0.8886 1.83 0.9972 5.51 
L75 3-layerLa 0.9978 5.64 0.9959 5.18 0.9972 5.58 0.9588  2.88 
L75 3-layerb 0.9991 6.49 0.9993 6.95 0.9845 3.80 0.9859 3.90 
L75 3-layerc 0.9884 4.02 0.9683 3.17 0.9883 4.17 0.9278 2.34 
* The dissolution test performed in apH change, bphosphate buffer pH 6.8 and cdistilled water. 
 
 
Owing to pH dependent solubility of this drug as 
described above, the drug release from this three-layer 
tablet in phosphate buffer pH 6.8 and pH change system 
was rather far from zero order kinetic release. Sustained 
release tablet prepared by hot-melt extrusion containing 
chitosan and xanthan gum was reported in terms of the 
influence of pH and ionic strength on the release of 
chlorpheniramine maleate.26 These pH and buffer 
species independent releases were attributable to the 
combination of the property of slow media uptake speed 
into a tablet due to the melt state of hot-melt extrusion 
process and inter- and intra-molecular hydrogelation of 
chitosan and xanthan gum. 
  
Table 5 Estimated parameters from curve fitting of drug 
dissolution in HCl buffer pH 1.2 to power law 
expression* 
Tablet K (mean ± S.D. x10-3) n (mean ± S.D.) 
L25 12.4560 ± 0.6852 0.6607 ± 0.0088 
L50 19.8030 ± 1.6500 0.6136 ± 0.0139 
L75 12.615 ± 0.6522 0.7648 ± 0.0093 
L25a 29.5860 ± 13.3520 0.5317 ± 0.0766 
L50 a 5.8822 ± 5.3428 0.8602 ± 0.1523 
L75 a 2.8974 ± 1.7028 1.0463 ± 0.1086 
L75 3L 4.2688 ± 0.8770 0.8709 ± 0.0330 
L75 3L a 26.297 ± 2.7126 0.5239 ± 0.0163 
L75 3Lb 9.6947 ± 1.2644 0.6580 ± 0.0199 
L75 3Lc 27.1211 ± 5.5262 0.5013 ± 0.0327 
* The dissolution test performed in apH change, bphosphate buffer pH 6.8 
and cdistilled water. 
 
Thai Pharmaceutical and Health Science Journal, Vol. 3 No. 1, Jan. – Apr. 2008  9 
Water uptake study and erosion study 
The water sorption of chitosan tablet in HCl buffer pH 
1.2 was rather lower than that in other dissolution fluids 
and the moderate erosion of tablet was found and it was 
complete at 8 hrs as presented in Figure 5. Protonation 
of chitosan in acid environment promoted the gradual 
hydration and erosion of the tablet. The water sorption 
and erosion values of chitosan tablet seemed stable after 
pH changed to 6.8 owing to the alteration from 
protonated form to unprotonated form. The water sorption 
in distilled water and phosphate buffer were high (Figure 
5) since the hydrophilic groups of chitosan structure 
could absorb the water but could not dissolve. The high 
erosion of tablet in distilled water was due to the partial 
tablet disintegration. Apparently, the water sorption and 
erosion of xanthan gum were greater than those in other 
dissolution fluids as shown in Figure 6. Absence or lower 
levels of ions in distilled water promoted the xanthan 
hydration ability whereas those ions in other dissolution 
fluids diminished the ability of this polymer.  
The values in Table 6 were the water sorption and 
erosion of different tablets from dissolution test at 12 hrs. 
The erosion of single layer tablet was enhanced as the 
amount of lactose was increased both in HCl buffer pH 
1.2 and pH change. The higher erosion and water 
sorption were found in the case of using HCl buffer pH 
1.2 comparing to those in pH change. Three layer tablet 
was completely eroded at 12 hrs and the erosion in pH 
change was higher than that in distilled water and 
phosphate buffer pH 6.8, respectively. By observation, 
the water absorption and erosion of three layer tablet in 
distilled water and phosphate buffer were similar. Since 
chitosan could not protonate in these fluids and xanthan 
gum might form complex with propranolol, the hydration 
of this matrix in these fluid could be limited. COO- of 
acetate or pyruvate groups of xanthan gum molecule27,28 
could form complex with amine group in propranolol 
structure contributing to the prevention of  over-swelling 
to sustain the drug release.  
 
 
 
Conclusions  
Covering both planar surfaces of middle tablet with 
polymeric mixture containing chitosan-xanthan gum-
lactose could modulate the release of propranolol HCl. 
Increased amount of lactose enhanced the drug release 
and diminished the pH sensitive drug release of tablet 
containing chitosan and xanthan gum. However, the drug 
release from the three layer tablets comprising this 
system was pH dependent. Particle size of chitosan did 
not significantly affect the drug release from the three 
layer tablets comprising this system.  
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Figure 5 Water sorption (A) and erosion (B) of tablet 
containing 400 mg chitosan in different 
dissolution fluids. 
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Figure 6 Water sorption (A) and erosion (B) of tablet 
containing 400 mg xanthan gum in different 
dissolution fluids. 
 
Table 6 Water sorption and erosion of tablets*   
Tablet Water Mass 
L25 1977.21+69.02 63.90+1.78  
L50 2675.76+107.94 79.01+0.80  
L75 n/d 100.00+0.00  
L25a 628.30+49.09 42.28+0.48  
L50 a 814.85+22.72 63.33+0.42  
L75 a 1099.36+31.58 83.49+0.14  
L75 3L n/d 100.00+0.00  
L75 3L a 1108.92+42.21 82.22+0.22  
L75 3Lb 846.30+65.79 64.50+0.68  
L75 3Lc 800.18+20.57 76.03+0.29 
n/d = not determined 
* The dissolution test performed in apH change, bphosphate buffer pH 6.8 
and cdistilled water. 
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